61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Cronos Group Inc
Closed
Sector Healthcare
1.97
Overview
Share price change
24h
Min
1.96
Max
1.97
Income | 17M 8.3M |
|---|---|
Sales | 6.5M 34M |
EPS | 0.02 |
Profit margin | 24.37 |
EBITDA | -2.2M -16M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | +5.53 upside |
Next Earnings | 27 Feb 2025 |
|---|
Market Cap | -32M 1.1B |
|---|---|
Previous open | 1.97 |
Previous close | 1.97 |
News Sentiment
By Acuity
15%
85%
19 / 392 Healthcare
Technical Score
By Trading Central
Confidence
Strong Bearish Evidence
Cronos Group Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Cronos Group Inc Forecast
Price Target
By TipRanks
5.53% upside
12 Months Forecast
Average 2.1 USD 5.53%
High 2.1 USD
Low 2.1 USD
Based on 1 Wall Street analysts offering 12 month price targets forCronos Group Inc - Dist in the last 3 months.
Sentiment
By Acuity
19 / 392 Healthcare
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Cronos Group Inc
Cronos Group Inc. is a Canada-based global cannabinoid company engaged in building intellectual property by advancing cannabis research, technology and product development. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s international brand portfolio includes Spinach, PEACE NATURALS, Lord Jones, Happy Dance and PEACE+. The Lord Jones, Happy Dance and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s subsidiaries include Cronos Israel G.S. Cultivation Ltd., Cronos Israel G.S. Manufacturing Ltd., Cronos Israel G.S. Store Ltd., and Cronos Israel G.S. Pharmacy Ltd.
